A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic — Elizabeth Mara Berry-Kravis
Genome editing holds great promise for the treatment of many genetic diseases; however its application in the clinic has been slow due to the lack of the safe delivery tools and significant cost and t
| Project title | A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic |
|---|---|
| Project number | 1UG3TR004713-01 |
| PI name | Elizabeth Mara Berry-Kravis |
| Institution | YALE UNIVERSITY |
| Funding mechanism | UG3 |
| Agency | NCATS |
| Award amount | $5.02M |
| Fiscal year | 2023 |
| Project start | 2023-09-20T00:00:00 |
| Project end | 2026-07-31T00:00:00 |
| Abstract | Genome editing holds great promise for the treatment of many genetic diseases; however its application in the clinic has been slow due to the lack of the safe delivery tools and significant cost and t |
| Key terms | <0-11 years old><17 year old><17 years of age><21+ years old><Acceleration><Adopted><Adult><Adult Hu |
$799/mo
Try GrantRadar →